Anavex Life Sciences Corp (AVXL)

[sokol]

Yes, we need to be patient, and you appear to be more patient than most. We want Anavex to succeed, and I believe the delay in the Rett trial is because Anavex has been collaborating with the Rett Foundation and the FDA to put together the most effective clinical trial it can under new FDA guidlines. Although the start of the trial has been delayed, it may be that all of this preparation involving the patient group and the FDA increases chances that AVXL 2-73 may be approved sooner. If the drug is approved for use for treating Rett patients, the drug will also be prescribed off label for a variety of CNS diseases that have no effective treatment.